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Abstract
Background: Both breastfeeding pattern and duration are associated with postnatal HIV acquisition; their relative
contribution has not been reliably quantified.
Methodology and Principal Findings: Pooled data from 2 cohorts: in urban West Africa where breastfeeding cessation at 4
months was recommended but exclusive breastfeeding was rare (Ditrame Plus, DP); in rural South Africa where high rates of
exclusive breastfeeding were achieved, but with longer duration (Vertical Transmission Study, VTS). 18-months HIV
postnatal transmission (PT) was estimated by Kaplan-Meier in infants who were HIV negative, and assumed uninfected, at
age .1 month. Censoring with (to assess impact of mode of breastfeeding) and without (to assess effect of breastfeeding
duration) breastfeeding cessation considered as a competing event. Of 1195 breastfed infants, not HIV-infected perinatally,
38% DP and 83% VTS children were still breastfed at age 6 months. By age 3 months, 66% of VTS children were exclusively
breastfed since birth and 55% of DP infants predominantly breastfed (breastmilk+water-based drinks). 18-month PT risk
(95%CI) in VTS was double that in DP: 9% (7–11) and 5% (3–8), respectively (p=0.03). However, once duration of
breastfeeding was allowed for in a competing risk analysis assuming that all children would have been breastfed for 18-
month, the estimated PT risk was 16% (8–28) in DP and 14% (10–18) in VTS (p=0.32). 18-months PT risk was 3.9% (2.3–6.5)
among infants breastfed for less than 6 months, and 8.7% (6.8–11.0) among children breastfed for more than 6 months;
crude hazard ratio (HR): 2.1 (1.2–3.7), p=0.02; adjusted HR 1.8 (0.9–3.4), p=0.06. In individual analyses of PT rates for specific
breastfeeding durations, risks among children exclusively breastfed were very similar to those in children predominantly
breastfed for the same period. Children exposed to solid foods during the first 2 months of life were 2.9 (1.1–8.0) times more
likely to be infected postnatally than children never exposed to solids this early (adjusted competing risk analysis, p=0.04).
Conclusions: Breastfeeding duration is a major determinant of postnatal HIV transmission. The PT risk did not differ
between exclusively and predominantly breastfed children; the negative effect of mixed breastfeeding with solids on PT
were confirmed.
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Introduction
HIV can be transmitted from mother to infant during
pregnancy, delivery or postnatally through breastfeeding, and is
a major cause of child mortality in sub-Saharan Africa [1].
Mother-to-child transmission of HIV occurring around delivery
can be largely prevented by peri-partum antiretroviral regimens
[2]. As a consequence, HIV transmission through breastmilk has
emerged as a more important mode of paediatric acquisition in
African breastfeeding populations [3], and its prevention remains
challenging [4].
Exclusive breastfeeding has been reported to carry a lower
postnatal HIV transmission risk than breastfeeding while concur-
rently feeding other milks, non-milk fluids, and solid foods [5–7].
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longer duration of breast-feeding is associated with a greater
cumulative risk of postnatal HIV transmission [3,8,9]. Both
breastfeeding pattern and duration are therefore associated with
acquisition of HIV, but to date a more precise estimate of
postnatal transmission at times points according to breastfeeding
exclusivity has not been reliably quantified in the same study. This
information is needed to ensure correct and appropriate messages
are provided during infant feeding counselling.
To investigate this question, we used a pooled dataset from two
studies, designed with a similar study approach, but with two
crucial differences with regard to infant feeding practices: an
urban West African setting where breastfeeding cessation at 4
months was recommended and where most women did not
practise exclusive breastfeeding [10]; and a rural South African
setting where emphasis was placed on the promotion of safer
breastfeeding practices, resulting in high rates of exclusive
breastfeeding, but where breastfeeding duration was much longer
[5].
Methods
Ethics statement
The Ditrame Plus study was granted ethics permission in Cote
d’Ivoire from the ethics committee of the National AIDS Control
Programme, and in France from the institutional review board of
the ANRS (Agence Nationale de Recherche sur le Sida et les
hepatites virales). The Vertical Transmission Study was approved
by the Biomedical Research Ethics Committee of the University of
KwaZulu-Natal, South Africa. All women included in the Ditrame
Plus study and in the Vertical Transmission Study provided
written informed consent.
Study design and interventions to prevent mother-to-
child transmission of HIV
We pooled together the data from two cohort studies, of which
inclusion procedures and research design have been described in
detail elsewhere: the Ditrame Plus study in Co ˆte d’Ivoire [11,12]
and the Vertical Transmission Study (VTS) in South Africa [5,13].
This pooled analysis was planned from the inception of both
studies, which contributed to avoid large differences between
studies, with regard to data collection and analysis [14]. This
approach allowed for standardized study design and standardized
definitions of exposure (see the subsequent ‘‘Collection of data on
infant feeding practice’’ paragraph) and confounder variables in
both individual studies.
From March 2001 to July 2003, pregnant, HIV-infected,
women aged $18 years from selected community-run health
facilities were enrolled in the Ditrame Plus study in Abidjan, Co ˆte
d’Ivoire [11,12]. All enrolled women received peri-partum
antiretroviral zidovudine with or without lamivudine, and single-
dose nevirapine to prevent mother-to-child transmission of HIV.
Single-dose nevirapine was offered to all infants. Antenatally, two
feeding options were discussed: complete avoidance of breastfeed-
ing or exclusive breastfeeding with early cessation from the fourth
month. Maternal infant feeding choice was supported, and
replacement feeding from birth, or from breastfeeding cessation
until 9 months of age, was provided free of charge. Mother-infant
pairs were offered clinical, nutritional and psychosocial follow-up
in study clinics from birth to two years.
From August 2001 to August 2004, pregnant, HIV-infected,
woman aged $16 years within selected clinics in rural, semi-urban
and urban KwaZulu-Natal, South Africa were enrolled in the
VTS [5,13]. Single-dose nevirapine was offered to all women and
infants. Women were counselled antenatally about infant feeding
options in line with WHO guidelines [15]. Emphasis was placed
on the promotion of exclusive breastfeeding for the first six months
for women choosing breastfeeding. From 2002, a six months’
supply of infant formula was offered free through the KwaZulu-
Natal prevention of mother-to-child transmission programme;
women could choose to access this supply from birth or any time
in the first 12 months after delivery. Breastfeeding mothers were
visited at home by counsellors who supported them in their infant
feeding choice every two weeks until the infant was aged 6 months.
Clinical follow-up of infants from birth to two years took place in
study clinics.
Collection of data on infant feeding practices
Similar questionnaires were used to collect infant feeding
practices in both studies [10,16,17]. As recommended [18–20],
infant feeding practices were recorded as 24-hour and seven-day
recall histories detailing all feeds, liquids and non-human milks
given to infants for every day of the preceding week. In both
studies, this information was recorded by trained field workers who
were not involved in infant feeding counselling.
Infant feeding practices were recorded weekly for the first 9
months, and then quarterly until age 24 months in the VTS
(41 visits); and weekly until 6 weeks of age, monthly until 9 months
of age, and every 3 months until the child’s second birthday in the
Ditrame Plus Study (18 visits). For this analysis, infant feeding
practices in the VTS were obtained only from visits shared with
the Ditrame Plus schedule, taking the VTS visit closest to the age
at which a Ditrame Plus monthly visit would have been made. We
assessed the appropriateness of this in a sensitivity analysis for the
VTS only which showed the same feeding behaviour despite the
reduced number of visits used (data not shown).
World Health Organization infant feeding definitions were used
[21–23]. A child who was breastfed at a given age while having
never received any other drink, food or non-human milk was
exclusively breastfed. Breastfed children having been given water
or water-based drinks only were predominantly breastfed from the
date of introduction of these fluids. A child who was breastfed at a
given age while also having received food-based fluids, solid foods
or non-human milk was considered mixed fed from the date of
introduction of these fluids or foods. In this paper we distinguish
two types of mixed feeding: breastmilk and food-based fluids or
solids; and breastmilk and non-human milk.
Diagnosis of paediatric HIV infection
In the Ditrame Plus Study, venous blood samples were collected
within 72 hours of delivery, at 4 to 6 weeks of age, at 2, 3, 6 and 9
months of age, and then every 3 months until 18 months of age.
An additional sample was obtained 2 months after breastfeeding
cessation. HIV status was established by quantitative HIV RNA
assay (Versant bDNA HIV RNA kit version 3.0, Bayer diagnostics,
Emeryville, USA, and TaqMan HIV-1 RNA real-time PCR from
2003) [24,25].
In the VTS, dried blood spot samples were obtained on filter
paper within 72 hours of delivery, at 4 to 6 weeks of age, monthly
until 9 months of age, and then every 3 months until 18 months of
age. HIV status was established by quantitative HIV RNA assay
(Nuclisens HIV-1 QT, Organon Teknika, Boxtel, Netherlands,
and Nuclisens EasyQ HIV-1, Biomerieux, Boxtel, Netherlands)
[26].
In both studies, paediatric HIV infection was defined as a
positive plasma HIV-1 RNA PCR at any age. Children with a
negative RNA PCR from a sample obtained at age $30 days who
Breastfeeding and HIV
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postnatally [27,28].
Statistical methods
This analysis was conducted among live born children of HIV-
infected mothers. We excluded infants not tested for HIV
infection, with unknown timing of infection or infected during
the peri-partum period, and with unknown or imprecise infant
feeding practices (at least one recall history missing in the first 2
weeks of life) or formula-fed from birth.
The Turnbull’s extension of the Kaplan-Meier procedure to
interval-censored data is recommended to assess the postnatal risk
of HIV transmission when the length of intervals between HIV
tests is long. However a standard Kaplan-Meier approach to the
analysis has been shown to be sufficient if most intervals are short
(less than 3 months) [28], which was the case in our two studies
(data not shown). We thus assessed cumulative HIV postnatal
transmission in the first 18 months of life by Kaplan-Meier
analysis; association with maternal and infant variables was
quantified in a Cox regression analysis [29,30]. Breastfeeding
pattern and duration were considered simultaneously in Cox
regression analyses. All multivariable analyses included a dummy
variable for study (VTS vs. Ditrame Plus) to account for differing
baseline risks between the two cohorts.
Postnatal HIV transmission (beyond 4 weeks of age) was
assessed in infants with a negative RNA PCR from a sample
obtained at age $30 days. The time of acquisition of infection was
assumed to be mid-way between the date of the last negative and
the first positive HIV RNA test [27].
Survival analysis was conducted to compare HIV postnatal
transmission between the two studies. We used two different
approaches for censoring to investigate separately the effects of
breastfeeding pattern and duration on the postnatal risk of HIV
transmission. First, infants were censored on the last day they had
been seen in study clinics or on the day they died; this approach
allowed us to investigate the impact of breastfeeding duration on
the postnatal risk of HIV transmission (as censoring did not
depend on breastfeeding duration). Second, infants were censored
on the date of breastfeeding cessation, unless they were still being
breastfed at the end of the study or if the date of the last negative
test was before the date of the breastfeeding cessation plus 30 days,
in the latter two cases the infants were censored on the date of the
last available negative HIV test. In this second approach,
breastfeeding cessation was considered a competing event which
allowed the comparison of the two cohorts with regard to the
probability of acquisition of HIV postnatally at a given age, which
assumes that all children of both studies had been breastfed until
that age. This approach allowed us to study the impact of the
breastfeeding pattern on the risk of HIV transmission, once the
breastfeeding duration had been fully taken into account.
Finally, we calculated smooth estimates of the hazard function
taking into account the instantaneous age-specific incidence of
postnatal transmission, using the penalized likelihood approach
and proportional hazard regression model for interval-censored
and left-truncated data (PHMPL) [31]. This analysis considered
the competing risk from breastfeeding cessation, and the estimates
obtained were expressed per 100 child-years of breastfeeding.
Upper and lower confidence bands of the estimate of age-specific
incidence were estimated using a Bayesian technique [31].
Statistical analyses were carried out using SAS software (version
9.1; SAS Institute, http://www.sas.com) and the PHMPL
computer program developed by the INSERM Research Centre
in Epidemiology and Biostatistics of the Bordeaux University
(version 1.2; http://www.isped.u-bordeaux2.fr/recherche/biostats/
Telechargement/PHMPL/us-Biostats-PHMPL.htm).
Results
Cohort profile and baseline characteristics
As shown in Table 1, 2190 HIV-infected women delivered in
the VTS (n=1460) and Ditrame Plus (n=730) studies, and 1195
breastfed infants who were HIV-negative at or after 30 days were
included in the present analysis.
Women from the VTS had a higher level of education, were less
likely to be employed in the formal economic sector, were less
likely to have piped water inside the home, had fewer previous
pregnancies and were less likely to be immuno-suppressed than
women from Ditrame Plus (Table 2).
Breastfeeding duration and pattern
Figure 1 shows that 90% of children in both studies were still
being breastfed by 3 months of age; but overall breastfeeding
duration was shorter in Ivorian than South African children:
median durations in months (inter-quartile range) were 4 (3–7) and
7 (5–13) in Ditrame Plus and in the VTS, respectively.
Most infants were exclusively breastfed for at least 3 months in
the Vertical Transmission Study and more than one third of them
for 6 months, whereas this practice was uncommon in the Ditrame
Plus study (Table 3). Although in both studies most infants were
exclusively or predominantly breastfed before 3 months of age,
thereafter infants in Ditrame Plus were more likely to be mixed fed
than infants in the VTS. This practice was associated with
breastfeeding cessation and the introduction of complementary
feeds which was recommended to occur earlier in Ditrame Plus
than in the Vertical Transmission Study. Mixed feeding outside
the period of transition when cessation of breastfeeding was
occurring with the intentional introduction of complementary
feeds (referred to as the weaning process in this paper), was rare in
both studies. For instance, 22% of infants had been exposed to any
type of mixed feeding by 3 months of age: 3% had been fed with
breastmilk plus solids and were not in the process of ‘being
weaned’, while the remaining 19% had received breastmilk and
non-human milk as part of their weaning process. Similarly, 78%
of infants who were mixed fed prior to 6 months completely
stopped breastfeeding within 2 weeks of first consuming the solid
food or animal milk that transfered them into the mixed feeding
category.
18-month postnatal transmission of HIV
Overall, 76 cases of confirmed HIV postnatal transmission were
diagnosed by 18 months of age, 13 in Ditrame Plus and 63 in the
Vertical Transmission Study. The overall 18-month probability of
postnatal acquisition of HIV in the Vertical Transmission Study
was double that in Ditrame Plus (Figure 2, Table 4). However, the
risk was similar in the two studies once duration of breastfeeding
had been taken into account in a competing risk analysis (Figure 3).
The estimated overall risk of postnatal acquisition of HIV was 9.0/
100 child-years of breastfeeding (95% confidence interval [CI],
6.2–11.7).
Infant feeding determinants of HIV postnatal
transmission
Every baseline characteristic in Table 2 was tested univariably
in a Cox regression analysis; variables not detailing infant feeding
practices used for adjustment in the following multivariable
analyses were chosen on the basis of their statistical significance
univariably and are reported in Table 4.
Breastfeeding and HIV
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breastfeeding duration and pattern on the risk of postnatal
transmission.
First, we investigated the effect of the breastfeeding duration.
The overall risk of postnatal HIV infection was 3.9% (95%CI,
2.3–6.5) among children breastfed for less than 6 months, and
8.7% (95%CI, 6.8–11.0) among children breastfed for 6 months or
more (unadjusted hazard ratio: 2.1, 95%CI 1.2–3.7, p=0.02).
Adjustment on study, education level, mother employment status
and antenatal maternal CD4 count reduced the hazard ratio to 1.8
(95%CI 0.9–3.4, p=0.06). Each additional month of breastfeed-
ing beyond 6 months of age was associated with a 1% risk of
acquisition of HIV (95%CI, 0.5–1.7).
Second, we compared the postnatal risk of HIV transmission in
exclusively and predominantly breastfed children. In individual
analyses of postnatal transmission rates for specific durations of
breastfeeding (1, 2, 3, 4, 5, or 6 months), the risks among children
exclusively breastfed (reference) were very similar to those
observed in children predominantly breastfed for the same
duration, with adjusted hazard ratios ranging from 0.75 (95%CI,
0.35–1.65) to 1.45 (95%CI, 0.26–8.27) and p-values ranging from
0.35 to 0.98.
Third, we assessed the effect of two different mixed feeding
practices on the postnatal risk of HIV transmission. Paradoxically,
children simultaneously exposed to breastmilk and non-human
milk were less likely to be HIV-infected postnatally than children
who were breastfed and unexposed to non-human milk, but
exposure to this type of mixed feeding was strongly correlated with
shorter breastfeeding cessation, which explained the direction of
the association. For instance, the median duration of breastfeeding
was shorter by 2 months among children exposed to mixed feeding
in the first 3 months of age compared to children exclusively or
predominantly breastfed during the same period (6.5 vs. 8.5
months, p,0.001). But, although rare, mixed feeding following the
early introduction of solid foods always increased the postnatal risk
of acquisition of HIV. Thus, children exposed at least once to
solids during the first 2 months of life were 2.9 times more likely to
be infected postnatally than children never exposed to solids
during the same period, in a competing risk analysis adjusting on
the variables in Table 4 (95%CI, 1.1–8.0, p=0.04). After
adjustment on these same variables, very similar results were
obtained in an analysis not considering weaning as a competing
risk, but taking into account breastfeeding duration as an
additional adjustment variable (less vs. more than 6 months):
adjusted hazard ratio, 3.6 (95%CI, 1.3–10.0, p=0.01). The
adverse effect of the introduction of solids in the first 2 months of
life on the postnatal risk of HIV infection was even stronger among
infants of women with baseline CD4 count above 200 cells/ml:
adjusted hazard ratio, 4.4 (95%CI, 1.6–12.3, p=0.005).
Taking into account the instantaneous age-specific incidence of
postnatal transmission by infant feeding practices, the estimated
postnatal risk of transmission would be 9.0/100 child-years of
exclusive breastfeeding (95% support interval [SI], 6.0–12.1),
8.5/100 child-years of predominant breastfeeding (95%SI, 1.2–
18.1), and 41.2/100 child-years of breastfeeding plus solids
(95%SI, 1.1–74.5).
Discussion
In this pooled analysis of West and South African cohorts, we
compared HIV postnatal transmission rates in two different
situations. In South Africa, more women practised exclusive
breastfeeding, but breastfeeding duration was longer; duration was
shorter in Co ˆte d’Ivoire, but most infants were predominantly
breastfed. We show that although crude HIV postnatal transmission
rates were twice as high in the South African study than in the Ivorian
one, transmission rates were very similar in the two studies once the
breastfeeding duration had been taken into account. Our interpre-
Table 1. Cohort profile.
Vertical Transmission
Study (South Africa)
Ditrame Plus
(Co ˆte d’Ivoire)
HIV-infected pregnant women included
1 1,775 808
exclusion of women with HIV-1 status non confirmed or
infected with HIV-2 only
93 4
exclusion of HIV-1 infected women lost to follow-up or
dead before delivery or who had spontaneous abortion
306 44
HIV-1 infected women having delivered 1,460 730
Birth outcomes 1,496 763
exclusion of second/third born of twins/triplets 36 33
exclusion of stillbirths 60 19
Single or first live born infants from HIV-
infected mother
1,400 711
exclusion of infants not tested for HIV infection
2 193 21
exclusion of infants with unknown timing of infection 50 3
exclusion of infants infected in peri-partum 125 42
exclusion of infants with imprecise mode of feeding
3 50 23
exclusion of formula fed infants 111 298
Mother-infant pairs included in the analysis 871 324
Vertical Transmission Study, South Africa, 2001–2007 - Ditrame Plus, Co ˆte d’Ivoire, 2001–2005.
1Vertical Transmission Study: from August 2001 to August 2004, Ditrame Plus: from March 2001 to July 2003.
2These children died or were lost-to-follow-up before we had an opportunity to test them for HIV infection.
3At least one recall history missing in the first 2 weeks of life.
doi:10.1371/journal.pone.0007397.t001
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postnatal HIV transmission, and this risk is not substantially different
between exclusively and predominantly breastfed children. In
addition, with regard to breastfeeding pattern, we confirm the
considerable negative effects of mixed breastfeeding with solids.
This pooled study has strengths, but also some limitations that
need to be addressed. The two studies constituted a large sample
size and were conducted in contexts representative of urban and
rural African settings. Moreover, this pooled analysis offered a
unique variation of both breastfeeding pattern and duration. Most
importantly, the methodology chosen to record infant feeding
practices was similar in both studies and more detailed than in
previous studies on this subject [6,7,32,33]. For instance, detailed
feeding information was collected at 6 weeks, 3 and 6 months only
in the Zvitambo trial [7], while we used here feeding information
collected 18 times during the first two years of life (with weekly,
monthly and then quarterly visits). This strategy minimized the
maternal recall bias that could have impaired the estimation of
breastfeeding characteristics, both in terms of pattern and duration
[18]. The two studies had different short-course peri-partum
antiretroviral regimens with the VTS using single-dose nevirapine
only and the Ditrame Plus study using zidovudine+/-lamivudine
with single-dose nevirapine. It is therefore possible that the more
efficacious regimens used in the Ditrame Plus study would have
led to reduced transmission in the early postnatal period. The
timing of HIV infection was estimated with the same level of
Table 2. Baseline characteristics of mother-infant pairs.
Characteristics Subcategory
Vertical Transmission
Study (South Africa)
Ditrame Plus
(Co ˆte d’Ivoire) p-value
N=871 N=324
Maternal age, median (IQR) 25 (21–29) 26 (23–30) 0.10
Maternal education, n( % )
none 60 (7) 141 (43) ,0.001
primary school 316 (36) 112 (35)
secondary school or higher 495 (57) 71 (22)
Mother employed in formal economic sector, n( % )
yes 115 (13) 172 (53) ,0.001
no 750 (87) 152 (47)
missing data 6 0
Water access, n( % )
piped water inside home 66 (8) 84 (26) ,0.001
piped water outside home 528 (61) 240 (74)
other sources of water 271 (31) 0
missing data 6 0
Number of previous pregnancies, median (IQR) 1 (0–2) 3 (2–5) ,0.001
Peri-partum antiretroviral prophylaxis, n( % )
sdNVP 871 (100) 0 -
scAZT+sdNVP 0 150 (46)
scAZT+sc3TC+sdNVP 0 174 (54)
Antenatal maternal CD4 count x10
6 cells/ml, median (IQR) 479 (334–647) 400 (270–535) 0.02
missing data 42 2
Antenatal maternal log10 plasma HIV RNA viral load,
median (IQR)
3.9 (3.3–4.5) 4.3 (3.7–4.7) 0.23
missing data 52 9
Female child, n( % )
yes 435 (50) 159 (49) 0.78
no 436 (50) 165 (51)
Multiple pregnancy (twins or triplets), n (%)
yes 22 (3) 12 (4) 0.27
no 849 (97) 312 (96)
Low birth weight (,2,500 g), n (%)
yes 84 (10) 87 (27) ,0.001
no 751 (90) 237 (73)
missing data 36 0
IQR: inter-quartile range; sdNVP: Nevirapine single dose; scZDV: short-course Zidovudine; sc3TC: short-course Lamivudine.
Pearson x
2 test or the Fisher exact test were used to compare categorical variables, and the Mann-Whitney U test was used to compare continuous variables.
doi:10.1371/journal.pone.0007397.t002
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when HIV testing of children was performed. However, the timing
of HIV infection was imprecise for 50 children in the VTS and 3
in Ditrame Plus. Most (80%) of these children had a first positive
test around 2 months of age with no previous negative test. It is
therefore likely that their infection occurred during the peri-
partum period, and we did not consider these infants as postnatally
infected. Assuming that these children had been infected in-utero
or through delivery, the peri-partum transmission rate was 12.5%
in the VTS, which is consistent with previous estimates among
women exposed to single dose nevirapine during labour [34,35].
In multivariable analyses, results were adjusted on all baseline
characteristic variables which differed between the two studies,
and a dummy variable for study was used to account for additional
differing baseline risks between the two cohorts. However, we
acknowledge that there may have been further confounding
factors we could not take into account.
The first key message of this study is the confirmation that
mixed feeding, particularly giving breastmilk and solids to infants,
is hazardous in terms of postnatal HIV transmission. It is essential
that whilst exclusive breastfeeding is promoted, the particular
dangers of mixed feeding with solids are emphasised to mothers.
We found that the concomitant use of breastmilk and non-human
milk was associated with a reduced risk of postnatal HIV
transmission. However, in both studies, this infant feeding practice
was part of the weaning process as recommended by study
protocols, and was therefore immediately preceding breastfeeding
cessation. A previous study showed that children simultaneously
exposed to breastmilk and non-human milk outside the weaning
process (e.g. not immediately before breastfeeding cessation) were
more likely to be infected than those exclusively breastfed [36].
These results underline the inherent problem in simultaneously
addressing both breastfeeding pattern and duration, as these
factors are confounded. Our findings also suggest that the
introduction of water-based fluids or fruit juices may not be
detrimental in terms of HIV transmission. This finding is
consistent with a study conducted in Zimbabwe suggesting that
HIV transmission through exclusive and predominant breastfeed-
ing was not different at 18 months (6.94, 95%CI: 2.03–12.89 and
8.56, 95%CI: 5.47–11.63, respectively), although there was a trend
Figure 1. Probability of being breastfed from birth until 18
months of age
*. * See Supporting information file S1 for the
probability with 95%CI.
doi:10.1371/journal.pone.0007397.g001
Table 3. Probabilities
1 of being exclusively, predominantly breastfed or mixed fed, and not being breastfed from birth until 9
months of age.
From birth
until
Probability of being
exclusively breastfed (95% CI)
Probability of being exclusively
or predominantly breastfed
(95% CI)
Probability of being mixed fed
(95% CI)
Probability of not being
breastfed any more (95% CI)
Vertical
Transmission
Study Ditrame Plus
Vertical
Transmission
Study Ditrame Plus
Vertical
Transmission
Study Ditrame Plus
Vertical
Transmission
Study Ditrame Plus
Age 1 Month 0.78 0.23 0.78 0.74 0.22 0.26 0.05 0.06
(0.75–0.80) (0.19–0.28) (0.75–0.80) (0.68–0.78) (0.20–0.25) (0.22–0.32) (0.04–0.07) (0.04–0.09)
Age 3 Months 0.66 0.15 0.67 0.55 0.33 0.45 0.10 0.09
(0.63–0.69) (0.11–0.19) (0.64–0.70) (0.49–0.60) (0.30–0.36) (0.40–0.51) (0.08–0.12) (0.06–0.13)
Age 6 Months 0.38 0.01 0.39 0.09 0.61 0.91 0.17 0.62
(0.35–0.42) (0.001–0.02) (0.36–0.42) (0.06–0.13) (0.58–0.64) (0.87–0.94) (0.14–0.19) (0.56–0.67)
Age 9 Months 0.02 0 0.02 0 0.98 100 0.51 0.79
(0.01–0.03) (0.01–0.04) (0.96–0.99) (0.48–0.55) (0.74–0.83)
1Probabilities were assessed with Kaplan-Meier analysis.
doi:10.1371/journal.pone.0007397.t003
Figure 2. Probability of remaining free from postnatal HIV
infection, weaning being not considered as a competing event
*. * See Supporting information file S2 for the probability with 95%CI.
doi:10.1371/journal.pone.0007397.g002
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nantly breastfed children [7]. Further support is provided by two
other studies showing no difference in mortality between
predominantly and exclusively breastfed children [37,38]. There
is no denying that women should be encouraged to give breastmilk
only for other reasons linked to maternal and infant health
[39–41]. However, given that exclusive breastfeeding is rarely
practised in African communities [10,42,43], unless extensive
counselling has been provided [5,44,45], it is helpful for policy
makers and health workers to appreciate the difference in risks for
HIV transmission between predominant feeding with water-based
fluids compared to mixed feeding with solids. More specifically,
counselling should focus on emphasizing the risks of mixed feeding
with solids which are more hazardous than predominant feeding
with water-based fluids. Moreover, future studies on HIV and
infant feeding should differentiate between predominant and
mixed feeding as they appear to have different implications.
This study also shows that breastfeeding duration is a major
determinant of transmission, but the public health implications of
this finding are highly dependent on the local context. Breastfeed-
ing cessation at 6 months should only occur with appropriate and
sustained nutritional counselling; practical support before stopping
breastfeeding; access to affordable and nutritionally adequate
complementary foods to replace breastmilk after breastfeeding
cessation; and careful clinical follow-up of the growth and health
of the non-breastfed child [46–52]. Therefore, the benefit of
breastfeeding cessation in terms of reduction of postnatal HIV
transmission has to be balanced with the potential risks for infant
health [53].
The risk of HIV transmission through breastmilk is strongly
associated with advanced immune deficiency. In our study, this risk
was 3.2 (95%CI, 1.8–5.7) and 3.0 (95%CI, 1.9–4.8) times higher
among women with respectivelybaseline CD4 count below 200 and
below 350, when compared to women above these thresholds.
Although further investigations are needed to explore the balance of
benefits and risks related to highly active antiretroviral therapy
(HAART) in breastfeeding mothers, it is expected to reduce
breastfeeding-associated HIV transmission among women eligible
for treatment because of their own health [54,55]. However, the
adverse effect of breastfeeding pattern and duration remains among
breastfeeding women who are not eligible for HAART. In our
study, among women with CD4 count above 200 cells per ml
(a common cut-off for treatment eligibility), breastfeeding beyond 6
months of age tended to be associated with a 1.7 increase (95%CI,
0.9–3.1) of postnatal transmission, while exposure to solids in the
first 2 months was associated with a 4.4 increase (95%CI, 1.6–12.3).
It is therefore important to continue to promote public health
messages on the benefits of optimal infant feeding practices despite
the increasing roll-out of HAART among African women.
Despite counselling for breastfeeding cessation at 6 months of
age, over 30% of women in the Vertical Transmission Study
were still giving some breastmilk at 12 months. There is,
therefore, an urgent need to find innovative strategies to retain
Figure 3. Probability of remaining free from postnatal HIV
infection, weaning being considered as a competing event
* 1. *
See Supporting information file S3 for the probability with 95%CI.
1 The
probability of HIV acquisition postnatally at a given age was calculated
assuming that all children had been breastfed until that age.
doi:10.1371/journal.pone.0007397.g003
Table 4. Factors associated with postnatal HIV transmission (excluding infant feeding practices), Cox Regression analysis.
Variables Subcategory N Postnatal HIV transmission Univariable analysis Multivariable analysis
18-month
cumulative risk 95% CI
Hazard
ratio 95% CI p
Adjusted
hazard ratio 95% CI p
Study
Ditrame Plus 324 4.6 2.6–7.8 1 - 0.03 1 - 0.38
Vertical Transmission Study 871 8.5 6.5–11.5 2.0 1.1–3.6 1.3 0.7–2.5
Secondary school
or higher
no 629 5.9 4.2–8.3 1 - 0.06 1 - 0.34
yes 566 8.8 6.7–11.7 1.6 1.0–2.4 1.3 0.8–2.0
Mother employed
yes 287 2.8 1.4–5.9 1 - 0.004 1 - 0.01
no 902 8.8 7.0–11.0 3.1 1.4–6.9 2.9 1.2–6.5
Maternal CD4 count
$200 cells/ml 1032 6.2 4.9–8.0 1 - 0.002 1 - ,0.001
,200 cells/ml 119 14.4 9.4–21.7 3.2 1.8–5.7 2.9 1.7–5.1
missing 44 12.1 4.7–31.5 0.7 0.2–1.9 0.5 0.2–1.5
doi:10.1371/journal.pone.0007397.t004
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the HIV transmission risk. Possibilities include: inactivation of
the virus with heat treatment [56,57] or with microbicides [58],
use of maternal highly active therapy to lower viral load in
breastmilk [59], or even vaccines [60]. Coupled with this,
further research is required to support the local production of
sustainable complementary foods [61]. Several interventions
are presently being investigated in a number of randomised
controlled studies and will assist finding solutions to the problem
of HIV transmission through breastmilk in Africa. For instance,
the administration of antiretroviral drugs to breastfed infants as
a post-exposure prophylaxis is an interesting strategy to reduce
postnatal HIV transmission [62,63], especially for children
born to women who present late in pregnancy; but this
intervention would need to be maintained throughout the
breastfeeding exposure and should ideally involve drugs that are
not likely to be associated with the development of viral
resistance mutations compromising future treatment options for
HIV-infected children.
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